198 related articles for article (PubMed ID: 28303836)
1. Carbapenem nonsusceptibility with modified
Choudhury D; Talukdar AD; Choudhury MD; Maurya AP; Chanda DD; Chakravorty A; Bhattacharjee A
Indian J Med Microbiol; 2017; 35(1):137-139. PubMed ID: 28303836
[TBL] [Abstract][Full Text] [Related]
2. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
[TBL] [Abstract][Full Text] [Related]
3. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC
J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the oprD porin gene by a novel insertion sequence ISPa195 associated with large deletion in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
Bocharova Y; Savinova T; Shagin DA; Shelenkov AA; Mayanskiy NA; Chebotar IV
J Glob Antimicrob Resist; 2019 Jun; 17():309-311. PubMed ID: 30684654
[TBL] [Abstract][Full Text] [Related]
5. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for and role of OprD protein in increasing minimal inhibitory concentrations of carbapenems in clinical isolates of Pseudomonas aeruginosa.
Hirabayashi A; Kato D; Tomita Y; Iguchi M; Yamada K; Kouyama Y; Morioka H; Tetsuka N; Yagi T
J Med Microbiol; 2017 Nov; 66(11):1562-1572. PubMed ID: 28984565
[TBL] [Abstract][Full Text] [Related]
7. Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan.
Sanbongi Y; Shimizu A; Suzuki T; Nagaso H; Ida T; Maebashi K; Gotoh N
Microbiol Immunol; 2009 Jul; 53(7):361-7. PubMed ID: 19563394
[TBL] [Abstract][Full Text] [Related]
8. Efflux system overexpression and decreased OprD contribute to the carbapenem heterogeneity in Pseudomonas aeruginosa.
Ikonomidis A; Tsakris A; Kantzanou M; Spanakis N; Maniatis AN; Pournaras S
FEMS Microbiol Lett; 2008 Feb; 279(1):36-9. PubMed ID: 18070070
[TBL] [Abstract][Full Text] [Related]
9. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
Lee JY; Ko KS
Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
[TBL] [Abstract][Full Text] [Related]
10. Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele.
Shu JC; Su LH; Chiu CH; Kuo AJ; Liu TP; Lee MH; Su IN; Wu TL
Microb Drug Resist; 2015 Apr; 21(2):149-57. PubMed ID: 25386722
[TBL] [Abstract][Full Text] [Related]
11. Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.
Ocampo-Sosa AA; Cabot G; Rodríguez C; Roman E; Tubau F; Macia MD; Moya B; Zamorano L; Suárez C; Peña C; Domínguez MA; Moncalián G; Oliver A; Martínez-Martínez L;
Antimicrob Agents Chemother; 2012 Apr; 56(4):1703-13. PubMed ID: 22290967
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem resistance in clinical isolates of Pseudomonas aeruginosa.
Walsh F; Amyes SG
J Chemother; 2007 Aug; 19(4):376-81. PubMed ID: 17855180
[TBL] [Abstract][Full Text] [Related]
14. Distribution of carbapenem resistance mechanisms in Pseudomonas aeruginosa isolates among hospitalised children in Poland: Characterisation of two novel insertion sequences disrupting the oprD gene.
Wołkowicz T; Patzer JA; Kamińska W; Gierczyński R; Dzierżanowska D
J Glob Antimicrob Resist; 2016 Dec; 7():119-125. PubMed ID: 27750158
[TBL] [Abstract][Full Text] [Related]
15. Development of carbapenem resistance in Pseudomonas aeruginosa is associated with OprD polymorphisms, particularly the amino acid substitution at codon 170.
Shu JC; Kuo AJ; Su LH; Liu TP; Lee MH; Su IN; Wu TL
J Antimicrob Chemother; 2017 Sep; 72(9):2489-2495. PubMed ID: 28535274
[TBL] [Abstract][Full Text] [Related]
16. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].
Santella G; Pollini S; Docquier JD; Almuzara M; Gutkind G; Rossolini GM; Radice M
Rev Panam Salud Publica; 2011 Dec; 30(6):545-8. PubMed ID: 22358400
[TBL] [Abstract][Full Text] [Related]
17. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
Hu YF; Liu CP; Wang NY; Shih SC
BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
[TBL] [Abstract][Full Text] [Related]
18. High-level resistance to meropenem in clinical isolates of Pseudomonas aeruginosa in the absence of carbapenemases: role of active efflux and porin alterations.
Chalhoub H; Sáenz Y; Rodriguez-Villalobos H; Denis O; Kahl BC; Tulkens PM; Van Bambeke F
Int J Antimicrob Agents; 2016 Dec; 48(6):740-743. PubMed ID: 28128097
[TBL] [Abstract][Full Text] [Related]
19. Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates.
Naenna P; Noisumdaeng P; Pongpech P; Tribuddharat C
Southeast Asian J Trop Med Public Health; 2010 May; 41(3):614-24. PubMed ID: 20578550
[TBL] [Abstract][Full Text] [Related]
20. Emergence of Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clinical Isolates Collected from Some Libyan Hospitals.
Mathlouthi N; Areig Z; Al Bayssari C; Bakour S; Ali El Salabi A; Ben Gwierif S; Zorgani AA; Ben Slama K; Chouchani C; Rolain JM
Microb Drug Resist; 2015 Jun; 21(3):335-41. PubMed ID: 25587875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]